| Short-term outcomes of an employer-sponsored diabetes management program at an ambulatory care pharmacy clinic. | |
| | |
MedLine Citation:
|
PMID: 22180556 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Purpose The impact of a collaborative, employer-sponsored diabetes management program on glycemic control and other clinical endpoints over 6-12 months is reported. Methods In a retrospective, chart-based evaluation, glycosylated hemoglobin (HbA(1c)) and related health status indicators were assessed among first-year enrollees in the Healthy Outcome Partnership for Employees (HOPE) with Diabetes Program, an ongoing program sponsored by the Wake Forest Baptist Health (WFBH) system. Diabetes management services were provided by pharmacists in collaboration with providers inside and outside the WFBH system. The primary endpoint was the mean change in HbA(1c) during follow-up averaging 8.2 months; secondary endpoints included changes in blood pressure, cholesterol, and triglyceride levels. Results Among the 98 patients included in the data analysis (75.5% women, 72.4% Caucasian), the mean HbA(1c) value decreased significantly during the study period (from 7.8% to 7.1%, p < 0.01); the proportion of patients at the recommended goal of an HbA(1c) of ≤7.0% rose from 40.8% to 56.1% (p < 0.01). HOPE Program enrollees also experienced significant improvements in mean triglyceride, total cholesterol, and blood pressure values (p < 0.05 for all). A subgroup of patients with initially poor glycemic control (HbA(1c) of ≥8.0%) had a mean HbA(1c) reduction of 1.7 percentage points during the study (p < 0.01), suggesting that the greatest benefits occurred in the highest-risk patients. Conclusion Among patients seen for at least six months at an employer-sponsored ambulatory care diabetes clinic managed by pharmacists, significant improvements from baseline in clinical end-points including HbA(1c) and blood pressure were demonstrated. |
| | |
Authors:
|
Virginia G Yoder; Dave L Dixon; Debra J Barnette; James R Beardsley |
Related Documents
:
|
3733716 - Evidence for pretranslational regulation of collagen synthesis by procollagen propeptides. 15983216 - Tissue factor as a link between wounding and tissue repair. 21194776 - Analysis of a primary care led diabetes annual review programme in a multi ethnic cohor... 6767656 - Comparison of collagen and glycosaminoglycan synthesis in attaching control and diabeti... 2547586 - Insulin-stimulated phosphorylation of a 195k protein from muscle and liver in the prese... 18617756 - Aqueous humor and serum levels of chromium in cataract patients with and without diabet... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists Volume: 69 ISSN: 1535-2900 ISO Abbreviation: Am J Health Syst Pharm Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2011-12-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9503023 Medline TA: Am J Health Syst Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 69-73 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Postdoctoral pharmacy industry fellowships: A descriptive analysis of programs and postgraduate posi...
Next Document: Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children.